Viewing Study NCT06504966


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-07 @ 9:37 AM
Study NCT ID: NCT06504966
Status: WITHDRAWN
Last Update Posted: 2025-05-11
First Post: 2024-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®
Sponsor: Xentria, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module